Portola Pharmaceuticals to Present at Bank of America

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Portola Pharmaceuticals to Present at Bank of America Merrill Lynch 2014 Health Care Conference

SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq: PTLA ) today announced that William Lis, chief executive officer, will present at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas on Thursday, May 15, 2014, at 10:00 a.m. Pacific Time.

The presentation will be webcast live and available for replay from Portola's website at www.portola.com in the Investor Relations section.

About Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals is a biopharmaceutical company developing product candidates that have the potential to represent significant advances in the fields of thrombosis and other hematologic diseases. The Company is advancing its three wholly-owned programs using novel biomarker and genetic approaches that may increase the likelihood of clinical, regulatory and commercial success of its first-in-class therapies. Portola's partnered program is focused on developing selective Syk inhibitors for inflammatory conditions.

Betrixaban

Portola's wholly-owned, oral, once-daily Factor Xa inhibitor betrixaban is being evaluated in the only biomarker-based Phase 3 study for hospital-to-home prophylaxis of venous thromboembolism (VTE) in acute medically ill patients. Betrixaban's distinct properties may have the potential to allow the agent to demonstrate efficacy without the significant increase in the rate of major bleeding that was seen in this patient population with other Factor Xa inhibitors. If approved, betrixaban could be the first anticoagulant for both hospital and post-discharge VTE prophylaxis and the standard of care in this large market of more than 30 million patients worldwide.    

Andexanet Alfa

Portola's second product candidate in the area of thrombosis, andexanet alfa, has the potential to be a first-in-class reversal agent to reverse the effects of Factor Xa inhibitors in patients who suffer a major bleeding episode or who require emergency surgery. Portola has entered into clinical collaboration agreements with all of the manufacturers of direct Factor Xa inhibitors -- Bristol-Myers Squibb and Pfizer (Eliquis ®  [apixaban]), Bayer HealthCare and Janssen Pharmaceuticals (XARELTO ® [rivaroxaban]), and Daiichi Sankyo (edoxaban) -- while retaining all commercial rights to andexanet alfa. Andexanet alfa has been designated as a Breakthrough Therapy by the U.S. Food and Drug Administration.

Cerdulatinib* (PRT2070)

Portola's product candidate in the area of hematologic cancer, cerdulatinib, is an orally available molecule that uniquely inhibits two validated tumor proliferation pathways -- spleen tyrosine kinase (Syk) and janus kinase (JAK). It is currently being evaluated in a Phase 1 study in patients with leukemias or lymphomas with a focus on genetically-defined subtypes, as well as in patients who have failed therapy due to relapse or acquired mutations.  

For more information, visit www.portola.com and follow the Company on Twitter @Portola_Pharma .

*Cerdulatinib is a proposed International Nonproprietary Name (pINN).

Investor Contact: Alexandra Santos Portola Pharmaceuticals 650.246.7239 Media Contact: Joey Fleury BrewLife 415.946.1090

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Replit Wins 2026 Microsoft Startup Partner Award

Updated Category News Views 133

Replit's Triumph in the Microsoft Ecosystem If there's one thing you come to expect from this dizzying dance of technology and business, it's that standout players get their due when they push the envelope. Replit just snagged a gleaming accolade by being named Microsoft's 2026 Partner of the Year for Startups. That's a hefty badge, especially coming from a giant like...

Continue Reading
Century Lithium Snags Key Permit for Demo Plant

Updated Category News Views 108

Navigating Critical Environmental Permits Alright folks, grab your hard hats, Century Lithium's making moves in the Nevada desert. The company just snagged a Water Pollution Control Permit (WPCP) for its Tonopah Airport demonstration facility. This isn't just a paper shuffle, it's a concrete leap toward getting their Angel Island project out of the memo phase and into...

Continue Reading
Kyndryl's Sovereignty Strategy Tackles Digital Resilience

Updated Category News Views 116

Driving Resilience Amidst Sovereignty Moves Hot off the press, Kyndryl is rolling out a beefed-up strategy to fortify operational resilience in the face of shifting digital sovereignty challenges. I’d say these guys got their fingers firmly on the geopolitical pulse, and they’re not messing around. “Maintaining critical IT operations is fundamental to business...

Continue Reading
Silicosis Crisis: Legal and Health Ramifications Loom

Updated Category News Views 83

The Hidden Dangers of Artificial Stone Here's the grim truth. Artificial stone countertops, loved by many for their aesthetics in kitchens and bathrooms, have a dark side that’s becoming increasingly hard to ignore. Loaded with more than 90% respirable crystalline silica, these materials spew out toxic dust when cut or polished. Once that dust gets airborne, workers...

Continue Reading
Adecoagro Hits Record EBITDA Amid Rain Challenges

Updated Category News Views 149

Adecoagro Breaks Records Despite Hurdles Picture this: Adecoagro's financials rolling in like a freight train, with nine-month adjusted EBITDA hitting an unprecedented $471.8 million. But hold on, it wasn't all smooth sailing. That kind of growth often comes with its own set of challenges, and this round wasn't any different for the South American agricultural...

Continue Reading
Disabled Veterans Win Legal Victory Against Firm

Updated Category News Views 0

Veterans Day Brings Justice for Disabled Veterans Amidst the patriotic celebration, over sixty thousand veterans found a new reason to commemorate this year's Veterans Day. A federal court just delivered a resounding verdict: Veterans Guardian must pay back disabled veterans three times the unlawful fees they collected. This ain't just a slap on the wrist, it's a stern...

Continue Reading
Real Estate Decisions in Hospitality: Buy or Lease?

Updated Category News Views 65

Venturing into Hospitality Real Estate If you're in the hospitality game, the question of whether to buy or to lease your property can loom like a shadow or shine like an opportunity. The latest episode of the Owner's Edge Podcast by Bielat Santore & Company dives into this headfirst, armed with over 45 years of brokering experience in hospitality transactions. They don't...

Continue Reading
Envision Energizes Türkiye's Green Power Future Ambitions

Updated Category News Views 53

Türkiye's Energy Vision Gains Momentum When you talk about energy transition, you can't ignore Türkiye's ambitious plans. Türkiye's Energy Minister, H.E. Alparslan Bayraktar, is rolling up his sleeves for a bold push into renewables. On the sidelines of COP31, he sat down with Envision Energy's main dealmaker, Kane Xu, to chew over how they can power up Türkiye’s...

Continue Reading
IOS Chicks to Shine on 'All Access' with Andy Garcia

Updated Category News Views 46

How Industrial Outdoor Storage Shapes Our World You drive by them every day, those sprawling lots of trucks and containers—you might not even give them a second glance. But they're the backbone of commerce, the unsung heroes ensuring everything runs like clockwork. IOS Chicks, a trailblazing all-women commercial real estate team, is slated to unravel this world on 'All...

Continue Reading
New Intubation Blade: A Potential Game-Changer in EMS

Updated Category News Views 0

Streamlining Emergency Medical Procedures A seasoned paramedic from Norfolk, Virginia, with a knack for solving practical problems, has devised a tool that could revolutionize the emergency medical field: the Dual Purpose Intubation Blade. This innovation is not just about simplifying the intubation process; it’s about taking a massive step forward in how emergency...

Continue Reading

Top 5 Most Recently Viewed Articles

Artera Expands Leadership Team to Enhance Federal Operations

Updated Category News Views 375

Artera Expands Leadership Team to Enhance Federal Operations Artera, a leading SaaS provider in digital health solutions, is making significant strides in its mission to support federal healthcare agencies. The company has recently announced key additions to its leadership team, aiming to strengthen its presence in the federal space. The new appointments include Kari...

Continue Reading
TPG to Reveal Q3 2024 Earnings in Upcoming Conference Call

Updated Category News Views 56

TPG Set to Release Third Quarter 2024 Financial Results TPG Inc. (NASDAQ: TPG), a renowned name in the global alternative asset management sector, is slated to unveil its financial results for the third quarter of 2024. This announcement is anticipated on a Monday morning before the markets open, providing investors with a timely update on the firm’s performance....

Continue Reading
ParaZero Advances with $187K Drone Safety Order for Production

Updated Category News Views 172

ParaZero Secures Major Purchase Order for Drone Safety Solutions In a notable development for the aerospace industry, ParaZero Technologies Ltd. (Nasdaq: PRZO) has successfully secured a significant purchase order worth $187,000. This order comes from a U.S.-based Advanced Air Mobility (AAM) company and represents a crucial milestone in ParaZero's mission to improve...

Continue Reading
Vallourec's Delphy Storage Revolutionizes Hydrogen Infrastructure

Updated Category News Views 224

Vallourec's Hydrogen Storage Breakthrough with Delphy Vallourec, a renowned leader in seamless tubular solutions, recently announced a significant safety qualification for its innovative hydrogen storage solution known as Delphy. This remarkable achievement, certified by DNV, marks a pioneering step forward in the safe storage of hydrogen, addressing the increasing demand...

Continue Reading
Investors Team Up for New Grifols Board Representation

Updated Category News Views 151

Investor Group Aims for Board Representation to Boost Governance at Grifols Flat Footed LLC, along with Mason Capital Management LLC and Sachem Head Capital Management LP—collectively known as the Investor Group—has taken a significant stake in Grifols, S.A., representing 7.72% of the company’s class A shares. In response to their concerns, they have officially...

Continue Reading